Adamed Pharma S.A. Tecnimede - Sociedade Técnico-Medicinal S.A.

Poland

All drugs from this manufacturer

  • SUNITINIB ADAMED

    The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma, and pancreatic neuroendocrine tumors (pNET) that are in the progressive phase and cannot be surgically removed.

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib maleate 16.7063 mg

    ATC: L01EX01

  • SUNITINIB ADAMED

    The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in the progressive stage and cannot be surgically removed.

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib maleate 33.4126 mg

    ATC: L01EX01

  • SUNITINIB ADAMED

    The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in the progressive phase and cannot be surgically removed.

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib maleate 50.1189 mg

    ATC: L01EX01

  • SUNITINIB ADAMED

    The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in the progressive phase and cannot be surgically removed.

    Dosage form: capsules, hard

    Active substance Dosage
    sunitinib maleate 66.825 mg

    ATC: L01EX01